The patch used in the study is approved in the United States for postherpetic neuralgia and in Europe for PNP arising from any etiology.
Even minor improvements in fibromyalgia symptoms, depression, anxiety, and pain can have a significant impact on the quality of life in patients with fibromyalgia.
Reports of pain may indicate a preclinical course of amyotrophic lateral sclerosis.
As the population ages, and as both the incidence of diabetes and the survival rates after chemotherapy treatment increase, the number of patients with neuropathic pain is expected to rise.
The VA and DoD issue a clinical practice guideline regarding opioid therapy for chronic pain in veterans.
Avoidance can lead to headache disability by reducing pain thresholds and preventing pain habituation.
The characteristics of migraine may change throughout a woman's reproductive stages, and may require different treatment strategies.
No significant between-group differences were observed for change in leg pain intensity and disability.
Clinically and statistically significant reductions in peripheral neuropathy were seen following neurofeedback.
Spinal cord stimulation using precision approach via 3D neural targeting shows superior efficacy in treating chronic axial low back pain compared with a trial-and-error method to achieve desired paresthesia.
Remote electrical stimulation appears to have similar efficacy to standard drug treatments, including triptans.
A significant decrease in migraine frequency was observed, but it is not clear how large a role placebo effect plays in treatment response.
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
The recommendations promote the use of hot compresses and physical therapy as first-line treatment of low back pain.
New research suggests that opioid addiction may be linked to a genetic variant, and more personalized treatment may help those with the change.
Interventions with clinical massage or guided imagery may help ease pain and anxiety in patients in a progressive care unit.
The abuse of opioids or other substances may cause short-term amnesia.
Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.
The new guidelines offer guidance on dosing, including reduced starting and maintenance dosing and safety precautions for diagnosing and treating complications.
The FDA instituted widespread updates to product labeling for opioid medications in December, 2016.
While likely a placebo effect, spinal manipulation may be an option for patients with migraine refractory to treatment.
Rates of severe pain were significantly higher in veterans with back and jaw pain, severe headaches or migraine, and neck pain.
The US FDA is requiring that label changes be made to reflect the risks involved with extended exposure to anesthetics and sedatives in children and pregnant women.
Recent findings offer a new avenue for the development of peripheral analgesics with minimal adverse effects.
The guidelines were developed by a group of RLS experts from the US and Europe who utilized the American Academy of Neurology's 2004 guideline development manual.
After treatment, there were marked decreases in visual analog scale (VAS)-pain, VAS-asthenia, severity of waking unrefreshed, tender point count, and Beck Depression Inventory.
Recovery time varies depending on which class of medication the patient is overusing.
The researchers observed a 47.5% increase in the percentage of participants who had a final pain score of 4 or less out of 10.
The group developed the algorithm through a year-long process of reviewing relevant published data.
Kratom may be used to develop nonaddictive alternatives to opioids.
Neurology Advisor Articles
- Vitamin D Deficiency Affects Cognition in Multiple Sclerosis
- Hypothalamus May Play a Central Role in Chronic Migraine
- An Interdisciplinary Approach to Advanced Parkinson's Care
- Migraine Attacks Associated With Reduced Dopamine Levels
- Polypharmacy in Schizophrenia May Have Adverse Effect on Cognition
- Alzheimer's Mortality Increasing, But So Is At-Home Care
- Special Diets, Supplements for Autism Not Backed by Solid Evidence
- In MS, Disease Duration, Lesion Load Predict Relapses and Disability Progression
- Ocrelizumab May Improve Cognitive Function in Relapsing Multiple Sclerosis
- Teriflunomide for MS Associated With Low Rates of Infection, Lymphopenia